0.00Open0.45Pre Close0 Volume18 Open Interest12.50Strike Price0.00Turnover65.47%IV13.45%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type0.3532Delta0.1789Gamma25.37Leverage Ratio-0.0143Theta0.0028Rho8.96Eff Leverage0.0118Vega
Stoke Therapeutics Stock Discussion
In the rapidly evolving world of biotechnology, companies like Stoke Therapeutics are pioneering groundbreaking treatments that could potentially change the lives of patients with severe diseases. The recent buzz surrounding Stoke Therapeutics, particularly their work on an anti-epilepsy drug, STK-001, underscores the transformative potential of RNA-based therapies in addres...
No comment yet